Federowicz I. Phase III clinical trial evaluating the use pazopanib in the treatment of kidney cancer - a discussion assumptions and results of the study. OncoReview [Internet]. 2012Mar.30 [cited 2024Jul.3];2(1(5):65-8. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/298